Patents by Inventor Karen L. Fearon

Karen L. Fearon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-IV
    Publication number: 20120231039
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: January 12, 2012
    Publication date: September 13, 2012
    Inventors: Karen L. FEARON, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same-II
    Patent number: 8222398
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: July 17, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • BIODEGRADABLE IMMUNOMODULATORY FORMULATIONS AND METHODS FOR USE THEREOF
    Publication number: 20120121622
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or nanocarrier.
    Type: Application
    Filed: January 25, 2012
    Publication date: May 17, 2012
    Applicant: DYNAVAX TECHNOLOGIES CORPORATION
    Inventors: Gary VAN NEST, Stephen Tuck, Karen L. Fearon, Dino Dina
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 8158768
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: April 17, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • Biodegradable immunomodulatory formulations and methods for use thereof
    Patent number: 8124590
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or nanocarrier.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: February 28, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen F. Tuck, Karen L. Fearon, Dino Dina
  • Chimeric immunomodulatory compounds and methods of using the same—IV
    Patent number: 8114418
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: February 14, 2012
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same
    Patent number: 8003115
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: August 10, 2007
    Date of Patent: August 23, 2011
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Biodegradable immunomodulatory formulations and methods for use thereof
    Publication number: 20110038896
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or nanocarrier.
    Type: Application
    Filed: June 19, 2007
    Publication date: February 17, 2011
    Applicant: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen Tuck, Karen L. Fearon, Dino Dina
  • IMMUNOMODULATORY COMPOSITIONS, FORMULATIONS, AND METHODS FOR USE THEREOF
    Publication number: 20100291218
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMO/MC) complexes comprising 3-6mer immunomodulatory oligonucleotides. The IMO/MC complexes may be covalently or non-covalently bound. Also provided are immunomodulatory compositions comprising a 3-6mer IMO encapsulated in an MC.
    Type: Application
    Filed: March 2, 2009
    Publication date: November 18, 2010
    Inventors: Karen L. FEARON, Dino DINA
  • Chimeric immunomodulatory compounds and methods of using the same—III
    Patent number: 7785610
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: August 31, 2010
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • IMMUNOSTIMULATORY SEQUENCE OLIGONUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20100184834
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: September 24, 2009
    Publication date: July 22, 2010
    Inventors: Dino DINA, Karen L. Fearon, Jason Marshall
  • Immunostimulatory sequence oligonucleotides and methods of using the same
    Patent number: 7745606
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Grant
    Filed: December 18, 2003
    Date of Patent: June 29, 2010
    Assignee: Dynavax Technologies Corporation
    Inventors: Dino Dina, Karen L. Fearon, Jason Marshall
  • CHIMERIC IMMUNOMODULATORY COMPOUNDS AND METHODS OF USING THE SAME-II
    Publication number: 20090317480
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: October 1, 2008
    Publication date: December 24, 2009
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Branched immunomodulatory compounds and methods of using the same
    Patent number: 7625872
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of cells and individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: December 17, 2003
    Date of Patent: December 1, 2009
    Assignee: Dynavax Technologies Corporation
    Inventor: Karen L. Fearon
  • IMMUNOMODULATORY POLYNUCLEOTIDES AND METHODS OF USING THE SAME
    Publication number: 20080207550
    Abstract: The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 28, 2008
    Inventors: Karen L. Fearon, Dino Dina
  • Chimeric immunomodulatory compounds and methods of using the same
    Publication number: 20080181909
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Application
    Filed: August 10, 2007
    Publication date: July 31, 2008
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Chimeric immunomodulatory compounds and methods of using the same—I
    Patent number: 7255868
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of individuals using the immunomodulatory compounds.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: August 14, 2007
    Assignee: Dynavax Technologies Corporation
    Inventors: Karen L. Fearon, Dino Dina, Stephen F. Tuck
  • Biodegradable immunomodulatory formulations and methods for use thereof
    Patent number: 7250403
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: July 31, 2007
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen Tuck, Karen L. Fearon, Dino Dina
  • Immunomodulatory formulations and methods for use thereof
    Patent number: 7183111
    Abstract: The invention provides new compositions and methods for immunomodulation of individuals. Immunomodulation is accomplished by administration of immunomodulatory polynucleotide/microcarrier (IMP/MC) complexes. The IMP/MC complexes may be covalently or non-covalently bound, and feature a polynucleotide comprising at least one immunostimulatory sequence bound to a nonbiodegradable microcarrier or nanocarrier.
    Type: Grant
    Filed: August 10, 2001
    Date of Patent: February 27, 2007
    Assignee: Dynavax Technologies Corporation
    Inventors: Gary Van Nest, Stephen Tuck, Karen L. Fearon, Dino Dina
  • Branched immunomodulatory compounds and methods of using the same
    Publication number: 20040136948
    Abstract: The invention provides immunomodulatory compounds and methods for immunomodulation of cells and individuals using the immunomodulatory compounds.
    Type: Application
    Filed: December 17, 2003
    Publication date: July 15, 2004
    Applicant: Dynavax Technologies Corporation
    Inventor: Karen L. Fearon